| One‐to‐many propensity score matching in cohort studies JA Rassen, AA Shelat, J Myers, RJ Glynn, KJ Rothman, S Schneeweiss Pharmacoepidemiology and Drug Safety 21 (S2), 69-80, 2012 | 431 | 2012 |
| Antidepressant use in pregnancy and the risk of cardiac defects KF Huybrechts, K Palmsten, J Avorn, LS Cohen, LB Holmes, JM Franklin, ... New England Journal of Medicine 370 (25), 2397-2407, 2014 | 424 | 2014 |
| Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners RJ Desai, JM Franklin bmj 367, 2019 | 420 | 2019 |
| Failure of investigational drugs in late-stage clinical development and publication of trial results TJ Hwang, D Carpenter, JC Lauffenburger, B Wang, JM Franklin, ... JAMA internal medicine 176 (12), 1826-1833, 2016 | 386 | 2016 |
| Effects of adjusting for instrumental variables on bias and precision of effect estimates JA Myers, JA Rassen, JJ Gagne, KF Huybrechts, S Schneeweiss, ... American journal of epidemiology 174 (11), 1213-1222, 2011 | 341 | 2011 |
| Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women BT Bateman, JM Franklin, K Bykov, J Avorn, WH Shrank, TA Brennan, ... American journal of obstetrics and gynecology 215 (3), 353. e1-353. e18, 2016 | 299 | 2016 |
| When and how can real world data analyses substitute for randomized controlled trials? JM Franklin, S Schneeweiss Clinical Pharmacology & Therapeutics 102 (6), 924-933, 2017 | 277 | 2017 |
| Metrics for covariate balance in cohort studies of causal effects JM Franklin, JA Rassen, D Ackermann, DB Bartels, S Schneeweiss Statistics in medicine 33 (10), 1685-1699, 2014 | 275 | 2014 |
| An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms CL Passaretti, JA Otter, NG Reich, J Myers, J Shepard, T Ross, KC Carroll, ... Clinical infectious diseases 56 (1), 27-35, 2013 | 272 | 2013 |
| Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer AS Kesselheim, JA Myers, J Avorn Jama 305 (22), 2320-2326, 2011 | 267 | 2011 |
| Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence JM Franklin, WH Shrank, J Pakes, G Sanfélix-Gimeno, OS Matlin, ... Medical care 51 (9), 789-796, 2013 | 241 | 2013 |
| Statins and congenital malformations: cohort study BT Bateman, S Hernandez-Diaz, MA Fischer, EW Seely, JL Ecker, ... bmj 350, 2015 | 231 | 2015 |
| Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE initiative JM Franklin, E Patorno, RJ Desai, RJ Glynn, D Martin, K Quinto, A Pawar, ... Circulation 143 (10), 1002-1013, 2021 | 230 | 2021 |
| Association of industry payments to physicians with the prescribing of brand-name statins in Massachusetts JS Yeh, JM Franklin, J Avorn, J Landon, AS Kesselheim JAMA internal medicine 176 (6), 763-768, 2016 | 217 | 2016 |
| Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis CH Feldman, LT Hiraki, WC Winkelmayer, FM Marty, JM Franklin, SC Kim, ... Arthritis & rheumatology 67 (6), 1577-1585, 2015 | 214 | 2015 |
| Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study AS Kesselheim, B Wang, JM Franklin, JJ Darrow Bmj 351, 2015 | 211 | 2015 |
| Effect of reminder devices on medication adherence: the REMIND randomized clinical trial NK Choudhry, AA Krumme, PM Ercole, C Girdish, AY Tong, NF Khan, ... JAMA internal medicine 177 (5), 624-631, 2017 | 210 | 2017 |
| A randomized study of how physicians interpret research funding disclosures AS Kesselheim, CT Robertson, JA Myers, SL Rose, V Gillet, KM Ross, ... New England Journal of Medicine 367 (12), 1119-1127, 2012 | 209 | 2012 |
| Empagliflozin and the risk of heart failure hospitalization in routine clinical care: a first analysis from the EMPRISE study E Patorno, A Pawar, JM Franklin, M Najafzadeh, A Déruaz-Luyet, ... Circulation 139 (25), 2822-2830, 2019 | 207 | 2019 |
| Matching by propensity score in cohort studies with three treatment groups JA Rassen, AA Shelat, JM Franklin, RJ Glynn, DH Solomon, ... Epidemiology 24 (3), 401-409, 2013 | 168 | 2013 |
Sebastian Schneeweiss, M.D., Sc.D.Professor of Medicine and Epidemiology, Harvard Medical SchoolAdresse e-mail validée de post.harvard.edu
